Another potential therapeutic, Minocycline is a microglial inhibitor which reduces BBB dysfunction by preventing production of glutamate, matrix metalloproteinases, and the proinflammatory cytokine, IL-1, and increasing the levels of cells responsible for the remyelination of neurons which would be relevant in treating AD [138, 140,141,142]
Topical results follow a fairly steady arc
Unlike GHRP-2 or GHRP-6, ipamorelin doesn't meaningfully raise cortisol or prolactin, making it a cleaner option for women who are sensitive to hormonal fluctuations
Patients who report feeling less bloated on GHK-Cu are likely experiencing a secondary effect of its systemic inflammation reduction rather than any specific metabolic action
Be the first to ask a question about this product